ALK rearrangements are uncommon but actionable oncogenic drivers in non–small cell lung cancer.
Hong Zheng, MM
Advertisement
Articles by Hong Zheng, MM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Sac-TMT Improves Survival vs Chemotherapy in Pretreated Endometrial Cancer
2
Cemiplimab Shows Real-World Efficacy in Advanced NSCLC Study
3
Pembrolizumab Improves PFS Over Chemo in dMMR Endometrial Cancer
4
Calderasib Regimen Shows Meaningful Responses in Frontline KRAS G12C+ NSCLC
5